Search

Now showing items 1-10 of 31

Promotion of exercise in the management of cystic fibrosis - summary of national meetings

Tomlinson, O. W.; Shelley, J.; Denford, S.; Barker, A. R.; Oades, Patrick; Williams, C. (European Society of Person Centered Healthcare, 2017)
Measurement of VO2max in clinical groups is feasible and necessary

Williams, C. A.; Saynor, Z.; Barker, A. R.; Oades, Patrick; Tomlinson, O. W. (American Physiological Society, 2017)
The oxygen uptake efficiency slope is not a valid surrogate of aerobic fitness in children with cystic fibrosis

Williams, C.; Tomlinson, O. W.; Chubbock, L. V.; Saynor, Z.; Oades, Patrick; Barker, A. R. (Wiley, 2017-10-24)
The effect of ivacaftor in adolescents with cystic fibrosis (G551D mutation): an exercise physiology perspective

Saynor, Z.; Barker, A. R.; Oades, Patrick; Williams, Craig A. (Wolters Kluwer, 2014-12-01)
PURPOSE: The purpose of this report was to evaluate the influence of 12 weeks of ivacaftor treatment on the aerobic function of 2 teenage patients with cystic fibrosis (CF; DeltaF508/G551D) using a maximal cardiopulmonary ...
Enteroviral meningoencephalitis in an infant: an increasingly recognised infection

Oades, Patrick; Ladhani, S. (BMJ, 2015-02-01)
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.

Crow, Y. J.; Chase, D. S.; Lowenstein Schmidt, J.; Szynkiewicz, M.; Forte, G. M. A.; Gornall, H. L.; Oojageer, A.; Anderson, B.; Pizzino, A.; Helman, G.; Abdel-Hamid, M. S.; Devriendt, K.; Di Rocco, M.; Fahey, M. C.; Fazzi, E.; Lim, M. J.; Ferrie, C. D.; Khan, N.; Gowrinathan, N. R.; McKee, S. A.; Gowrishankar, K.; Oades, Patrick; Hanrahan, D.; King, M. D.; Kirk, E. P.; Kumar, R.; Ramesh, V.; Lin, J.-P. S-M; Lagae, L.; Landrieu, P.; Lauffer, H.; Laugel, V.; Olivieri, I.; Roubertie, A.; Moroni, I.; Linnankivi, T.; Rasmussen, M.; Mackay, M. T.; Marom, D. R.; Morton, J. E. V.; Salvatici, E.; Moutard, M.-L.; Tacke, U.; Ostergaard, J. R.; Murray, K.; Nabbout, R.; Nampoothiri, S.; Nunez-Enamorado, N.; Tonduti, D.; Régal, L.; Pérez-Dueñas, B.; Tan, T. Y.; Prendiville, J. S.; Segers, K. A.; Ricci, F.; Valente, E. M.; Rio, M.; Webb, H. J.; Rodriguez, D.; Sinha, G. P.; Soler, D.; Spiegel, R.; Livingston, J. H.; te Water Naude, J.; Stödberg, T. I.; Straussberg, R.; Swoboda, K. J.; Suri, M.; Whitehouse, W. P.; Abdel-Salam, G. M.; Van Coster, R. N.; Wee Teik, K.; Rozenberg, F.; Thomas, M. M.; Till, M.; van der Knaap, M. S.; Ackroyd, S.; Vassallo, G.; Bahi-Buisson, N.; Whitney, R. N.; Vijzelaar, R.; Vogt, J.; Wallace, G. B.; Wassmer, E.; Bernard, G.; Lebon, P.; Zaki, M. S.; Bailey, K. M.; Zuberi, S. M.; Aeby, A.; Vanderver, A.; Bianchi, M.; Orcesi, S.; Cereda, C.; Rice, G. I.; Agosta, G.; Albin, C.; Allon-Shalev, S.; Crichiutti, G.; Barnerias, C.; Arellano, M.; Ariaudo, G.; Aswani, V.; Babul-Hirji, R.; Chandler, K. E.; Baildam, E. M.; Billette de Villemeur, T.; Barth, M.; Dabydeen, L.; Battini, R.; Beresford, M. W.; Blair, E. M.; Bloom, M.; Burlina, A. B.; Figueiredo, A.; Chitayat, D. A.; Carpanelli, M. L.; Carvalho, D. R.; Castro-Gago, M.; Cavallini, A.; Isidor, B.; Dale, R. C.; Collins, A. E.; Gener, B.; Sierra Corcoles, C.; Cordeiro, N.J. V.; D'Arrigo, S.; Kara, B.; De Goede, C. G E L; La Piana, R.; De Laet, C.; De Waele, L.M. H.; Denzler, I.; Desguerre, I.; Marques Lourenço, C.; Goizet, C. (Wiley, 2015-02)
Aicardi-Goutières syndrome is an inflammatory disease occurring due to mutations in any of TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR or IFIH1. We report on 374 patients from 299 families with mutations in these ...
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study

Rice, G. I.; Forte, G. M. A.; Szynkiewicz, M.; Chase, D. S.; Aeby, A.; Abdel-Hamid, M. S.; Ackroyd, S.; Allcock, R.; Bailey, K. M.; Balottin, U.; Barnerias, C.; Bernard, G.; Bodemer, C.; Botella, M. P.; Cereda, C.; Chandler, K. E.; Dabydeen, L.; Dale, R. C.; De Laet, C.; De Goede, C. G E L; del Toro, M.; Effat, L.; Enamorado, N. N.; Fazzi, E.; Gener, B.; Haldre, M.; Lin, J.-P. S-M; Livingston, J. H.; Lourenco, C. M.; Marques, W.; Oades, Patrick; Peterson, P.; Rasmussen, M.; Roubertie, A.; Schmidt, J. L.; Shalev, S. A.; Simon, R.; Spiegel, R.; Swoboda, K. J.; Temtamy, S.A.; Vassallo, G.; Vilain, C.N.; Vogt, J.; Wermenbol, V.; Whitehouse, W. P.; Soler, D.; Olivieri, I.; Orcesi, S.; Aglan, M. S.; Zaki, M. S.; Abdel-Salam, G. M. H.; Vanderver, A.; Kisand, K.; Rozenberg, F.; Lebon, P.; Crow, Y. J. (Elsevier, 2013-12)
Airflow limitation following cardiopulmonary exercise testing and heavy-intensity intermittent exercise in children with cystic fibrosis.

Stevens, D.; Oades, Patrick; Williams, Craig A. (Springer, 2015-02)
The clinical importance of exercise testing and training in the healthcare management of young patients with cystic fibrosis (CF) is growing. The aim of the present study was to determine the incidence of airflow limitation ...
Impaired aerobic function in patients with cystic fibrosis during ramp exercise.

Saynor, Z.; Barker, A. R.; Oades, Patrick; Williams, Craig A. (Wolters Kluwer, 2014-12)
This study aimed to document the matching of muscle O2 delivery to O2 use in young patients with cystic fibrosis (CF) from muscle deoxygenation (HHb) dynamics during ramp exercise.
Pulmonary oxygen uptake kinetics are slowed in young patients with cystic fibrosis during very heavy but not moderate intensity cycling exercise

Saynor, Z.; Barker, A. R.; Oades, Patrick; Williams, Craig A. (LWW, 2016)

Search

Filters